Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0IY0R
|
||||
| Former ID |
DIB008478
|
||||
| Drug Name |
Viquidacin
|
||||
| Synonyms |
AVE-4221; AVE-6971; NXL-101; Topoisomerase IV inhibitor antibacterials, Novexel
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Bacterial infections [ICD9: 001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104; ICD10:A00-B99] | Preclinical | [547573] | ||
| Company |
Aventis Pharma AG
|
||||
| Formula |
C25H29FN2O4S2
|
||||
| Canonical SMILES |
s1c(ccc1)SCCN1C[C@@H]([C@@H](CC1)CC[C@@H](c1c(cnc2c1cc(<br />cc2)OC)F)O)C(=O)O
|
||||
| CAS Number |
CAS 904302-98-3
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Bacterial DNA gyrase | Target Info | Modulator | ||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.